Gene · 1890
Papers4,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Pediatric Intestinal Pseudo-Obstruction: An International Survey on Diagnostic and Management Strategies in the European Reference Network for Rare Inherited and Congenital Anomalies Intestinal Failure Teams. | J Pediatr Gastroenterol Nutr | 2023 | 37027146 | PubTator, text mining | PubMed |
| Rs11479 in Thymidine Phosphorylase Associated with Prognosis of Patients with Colorectal Cancer Who Received Capecitabine-Based Adjuvant Chemotherapy. | Pharmgenomics Pers Med | 2023 | 37025557 | PubTator, text mining | PubMed |
| iBRIDGE: A Data Integration Method to Identify Inflamed Tumors from Single-cell RNA-Seq Data and Differentiate Cell Type-Specific Markers of Immune-Cell Infiltration. | Cancer Immunol Res | 2023 | 37023414 | PubTator, text mining | PubMed |
| Immune evasion strategy involving propionylation by the KSHV interferon regulatory factor 1 (vIRF1). | PLoS Pathog | 2023 | 37023208 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Adjuvant therapy of biliary tract cancers. | Ther Adv Med Oncol | 2023 | 37007632 | PubTator, text mining | PubMed |
| Thymidine phosphorylase as a molecular target for quercetin-incorporated collagen matrix in the prevention of hand-foot syndrome induced by capecitabine in rats. | Can J Physiol Pharmacol | 2023 | 37001149 | PubTator, text mining | PubMed |
| The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent. | Cancer Chemother Pharmacol | 2023 | 37000221 | PubTator, text mining | PubMed |
| Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond. | World J Gastroenterol | 2023 | 36998426 | PubTator, text mining | PubMed |
| Behavioral variant frontotemporal dementia in a 23-year-old man. | Neurocase | 2023 | 36998234 | PubTator, text mining | PubMed |
| Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer. | Front Oncol | 2023 | 36994201 | PubTator, text mining | PubMed |
| Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-κB Non-Canonical Pathway and Mitochondrial Remodeling. | Viruses | 2023 | 36992454 | PubTator, text mining | PubMed |
| The Role of Reprogrammed Glucose Metabolism in Cancer. | Metabolites | 2023 | 36984785 | PubTator, text mining | PubMed |
| The Role of Primary Mitochondrial Disorders in Hearing Impairment: An Overview. | Medicina (Kaunas) | 2023 | 36984609 | PubTator, text mining | PubMed |
| Biomarker-Development Proteomics in Kidney Transplantation: An Updated Review. | Int J Mol Sci | 2023 | 36982359 | PubTator, text mining | PubMed |
| Transcriptomic Studies on Intracranial Aneurysms. | Genes (Basel) | 2023 | 36980884 | PubTator, text mining | PubMed |
| Influence of Single-Nucleotide Polymorphisms on Clinical Outcomes of Capecitabine-Based Chemotherapy in Colorectal Cancer Patients: A Systematic Review. | Cancers (Basel) | 2023 | 36980706 | PubTator, text mining | PubMed |
| Modulation of Nrf2/HO-1 by Natural Compounds in Lung Cancer. | Antioxidants (Basel) | 2023 | 36978983 | PubTator, text mining | PubMed |
| Thymidine Phosphorylase Deficiency or Inhibition Preserves Cardiac Function in Mice With Acute Myocardial Infarction. | J Am Heart Assoc | 2023 | 36974758 | PubTator, text mining | PubMed |
| Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review. | Signal Transduct Target Ther | 2023 | 36964133 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1890/papers?page=17